IPO

Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)

WSW, NY, 20th March 2026, FinanceWire … Read More

Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)

WSW, NY, 20th March 2026, FinanceWire … Read More

Duke Robotics Lands $1M+ Contract as Trump’s $1.9B Initiative Creates Tailwind Drone Innovator (OTCQB: DUKRD)

WSW, NY, 19th March 2026, FinanceWire … Read More

Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)

WSW, NY, 19th March 2026, FinanceWire … Read More

PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention

WSW, NY, 18th March 2026, FinanceWire … Read More

Duke Robotics Could Be One of the Underdog Companies Emerging From Israel’s Drone Tech Boom (OTCQB: DUKRD)

WSW, NY, 12th March 2026, FinanceWire … Read More

Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy

WSW, NY, 12th March 2026, FinanceWire … Read More

Money Expo Mexico 2026 Starts with Historic Footfall in Latin America

Mexico, Mexico, 19th February 2026, FinanceWire … Read More

Edgen Launches Autonomous AI Intelligence System for Real-Time Market Analysis

Hong Kong, Hong Kong, 12th February 2026, FinanceWire … Read More

Entera Bio Attracts Former Pfizer Group President as It Enters a New Phase (NASDAQ: ENTX)

WSW, NY, 9th February 2026, FinanceWire … Read More